Thus, similar to the results obtained following PTX3 expression in tumor cells, the systemic production of PTX3 in transgenic TgN(Tie2-hPTX3) mice results in a significant inhibition of both tumor cells as well as of different FGF/FGFR-dependent components of tumor microenvironment. Here, TEK is linked to neoplasm.